Annovis Bio Inc.

NYSE: ANVS · Real-Time Price · USD
2.73
0.01 (0.37%)
At close: Aug 15, 2025, 3:59 PM
2.74
0.37%
After-hours: Aug 15, 2025, 04:10 PM EDT

Annovis Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a
Operating Income
-26.7M -45.03M -25.51M -14.54M
Interest Income
331.85K 667.9K 182.71K 13.34K
Pretax Income
-24.59B -56.2M -25.33M -14.49M
Net Income
-24.59B -56.2M -25.33M -14.49M
Selling & General & Admin
6.7M 6.24M 9M 6.06M
Research & Development
20M 38.79M 16.52M 8.48M
Other Expenses
1K n/a -1K -37K
Operating Expenses
26.7M 45.03M 25.51M 14.5M
Interest Expense
1.85M n/a n/a n/a
Selling & Marketing Expenses
100K n/a n/a n/a
Cost & Expenses
26.7M 45.03M 25.51M 14.5M
Income Tax Expense
n/a n/a n/a -50.09K
Shares Outstanding (Basic)
12.18M 9.02M 8.16M 7.63M
Shares Outstanding (Diluted)
12.23M 9.02M 8.16M 7.63M
EPS (Basic)
-2.02K -6.23 -3.1 -1.9
EPS (Diluted)
-2.01K -6.23 -3.1 -1.9
EBITDA
-22.74M -45.03M -25.33M -14.5M
EBIT
-22.74M -45.03M -25.33M -14.49M
Depreciation & Amortization
n/a n/a 25.51M 14.54M